Theravance Biopharma share price logo

Theravance Biopharma

US: TBPH

$17.03

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 23 Sep 2026

Theravance Biopharma Stock Performance

as on September 24, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $17.02
    $17.07
    downward going graph

    0.06%

    Downside

    0.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.08
    $21.03
    downward going graph

    23.19%

    Downside

    23.49%

    Upside

    downward going graph

Theravance Biopharma share price movements today

Previous Close
$17.03
Open
$17.05
Volume
3.0M
Day's Low - High
$17.02 - $17.07
52 Week Low - High
$13.08 - $21.03

Theravance Biopharma Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Theravance Biopharma Stock Fundamentals & Key Indicators

Check Theravance Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

1.0638

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

16.01

Industry PE ratio

0.00

PEG Ratio

0.05

EBITDA

68.5M

Revenue (TTM)

104.3M

Profit Margin

89.40%

Return On Equity TTM

19.40%

Theravance Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Theravance Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Theravance Biopharma image
Theravance Biopharma
Neutral$-NA16.0189.40%0.00%
Moderna image
Moderna
Neutral$88.5B-36.40%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B208.09%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B45.26%19.7685.77%0.40%

Analyst Recommendation on Theravance Biopharma Stock

Based on 3 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'HOLD' rating for Theravance Biopharma. Average target price of $17.67

Theravance Biopharma Share Price Target

Get share price movements and forecasts by analysts on Theravance Biopharma.

What analysts predicted

3.62%UPSIDE

Target Price

$17.67

Current Price

$17.03

Analyzed by

3 Analysts

High

$17

Target

$17.67

Low

$17

Theravance Biopharma target price $17.67, a slight upside of 3.62% compared to current price of $17.03. According to 3 analysts rating.

Theravance Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
14
14
16
18
15
26
19
45
17
20
Gross Profit
5
4
7
9
3
15
11
44
17
19
Operating Income
-11
-15
-10
-9
-14
-2
-6
17
-5
0
EBITDA
-9
-12
-8
-7
-13
74
-1
75
-5
0
Interest Expense
0
0
0
0
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
1
0
1
Income Before Tax
-10
-15
-10
-8
-14
73
-2
73
-6
-4
Income Tax Expense
1
1
2
6
0
18
-6
12
-1
1
Net Income
-11
-16
-12
-15
-13
54
3
61
-4
-5
Net Profit Margin
38.16%
30.18%
45.06%
49.59%
25.58%
59.95%
59.42%
96.72%
100.00%
93.04%

Theravance Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
15
60
73
71
55
51
57
64
107
Gross Profit
9
59
73
71
-138
-12
16
26
101
Operating Income
-260
-238
-251
-297
-257
-91
-56
-46
-13
EBITDA
-259
-212
-203
-287
-232
-76
-51
-38
137
Interest Expense
8
10
31
8
8
6
2
2
2
Depreciation
4
3
6
6
4
3
2
3
5
Income Before Tax
-271
-226
-241
-303
-265
-92
-49
-44
129
Income Tax Expense
13
-10
-5
-8
0
0
5
11
23
Net Income
-285
-215
-236
-278
-199
872
-55
-56
105
Net Profit Margin
60.81%
98.82%
100.00%
100.00%
-250.12%
-23.46%
29.26%
41.53%
94.87%

Theravance Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-16
-12
-15
-13
54
3
61
-4
-5
Operating Cash Flow
-1
-4
-5
0
43
208
-6
-6
73
-8
Investing Cash Flow
17
-3
-17
15
30
-36
-100
0
52
-60
Financing Cash Flow
-1
0
0
0
0
0
0
-1
-5
4
Change in Cash
14
-7
-22
14
72
171
-107
-6
120
-64

Theravance Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-285
-215
-236
-294
-265
-92
-55
-56
105
Operating Cash Flow
-201
-112
-238
-250
-207
-186
-26
-11
238
Investing Cash Flow
-56
176
-83
10
124
1,154
-32
12
-105
Financing Cash Flow
1
225
1
263
91
-758
-198
-2
-3
Change in Cash
-255
289
-319
23
8
208
-258
-1
130

Global Institutional Holdings in Theravance Biopharma

Check out the Institutions with significant holdings in Theravance Biopharma.

Funds
Holdings
iShares
4.64%
Vanguard
4.10%
VANGUARD INDEX FUNDS
3.35%
Delaware Group Equity Funds IV
1.21%
SPDR
1.03%
See all

Theravance Biopharma News & Key Events

  • img

    Today's Timeline - 29 June

    Mon, 06:14 PM

    -

    Zymeworks to acquire Theravance for $17 per share, totaling $929 million, with contingent value rights for shareholders.

Insights on Theravance Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, TBPH stock has moved up by 0.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 17.69M → 20.73M (in $), with an average increase of 14.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TBPH has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 582.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 61.02M → -5.89M (in $), with an average decrease of 63.8% per quarter

About Theravance Biopharma

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
OrganisationTheravance Biopharma
Headquarters901 Gateway Boulevard, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEORick E. Winningham

FAQs

What is Theravance Biopharma share price today?

Theravance Biopharma share price today is $17.03 as on at the close of the market. Theravance Biopharma share today touched a day high of $17.07 and a low of $17.02.

What is the 52 week high and 52 week low for Theravance Biopharma share?

Theravance Biopharma share touched a 52 week high of $21.03 on and a 52 week low of $13.08 on . Theravance Biopharma stock price today i.e. is closed at $17.03,which is 19.02% down from its 52 week high and 30.20% up from its 52 week low.

How to invest in Theravance Biopharma Stock (TBPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Theravance Biopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Theravance Biopharma Stock (TBPH) from India?

Indian investors can start investing in Theravance Biopharma (TBPH) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Theravance Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Theravance Biopharma share’s latest price of $17.03 as on September 24, 2026 at 8:45 am IST, you will get 0.5872 shares of Theravance Biopharma. Learn more about fractional shares .